Events, By Category and Date:
» Go to news mainOn what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
Posted by nte on
February 24, 2023
in
In Print
Image credit: CBC News
Pappin J, Bavli I, Herder M. On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data. Clin Trials. 2022 Oct;19(5):584-590. doi: 10.1177/17407745221108436. Epub 2022 Aug 4. PMID: 35924783; PMCID: PMC9523806.
Recent News
- On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
- Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada
- Fair pricing of “old” orphan drugs: considerations for Canada’s orphan drug policy
- Matthew Herder Resigns from Patented Medicine Prices Review Board
- Podcast or Perish: Episode 040: Françoise Baylis
- Bioethicist Françoise Baylis asks why humans think 'they can just take everything'
- Killam Prize winners discuss research in Canada
- World‑renowned Dalhousie bioethicist and battery pioneer win prestigious Killam Prize